AVATAR MEDICAL

Avatar Medical is a developer of an FDA-cleared and CE-marked VR and 3D medical imaging software platform that transforms CT and MR images into interactive 3D patient avatars for surgical planning and patient consultation. The platform, Avatar Medical Vision, pulls DICOM data from PACS or locally with no preprocessing, instantly generates 3D views of areas of interest, and enables real-time exploration on screen or in virtual reality. The company also offers Eonis Vision, a next-generation AR solution for clinical use. Clinical applications span neurosurgery, oncology, ENT and OMS, orthopedic surgery, cardiovascular surgery, vascular surgery, and urology. The platform enhances patient-doctor communication by turning complex medical images into clear 3D insights, supporting patient engagement before and after surgery, surgical planning, multidisciplinary collaboration, and intraoperative display. The company has received awards at CES 2026 including CES Innovation, and partners with AP-HP, Sorbonne University, and multiple hospitals. Founded in 2020 and headquartered in Paris, France, Avatar Medical has raised approximately 5.4 million at the Seed stage with investors including Acorn Pacific Ventures, EIC Fund, HHS, EIT Health, Rives Croissance, and GO CAPITAL.